Expanding Interventions for Automatically Maintained SIB
NCT ID: NCT06739616
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2023-04-18
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
(1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match.
Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While NCR and DR have demonstrated efficacy, the literature lacks critical evaluation of successful application of these interventions to reduce automatically maintained SIB along at least two dimensions. 1) No studies demonstrate longevity of treatment effects. In most studies, demonstrations of efficacy have occurred during brief (5-15 min) sessions conducted one to several times per day. Interventions may be successful during those brief time periods, but it remains unknown whether intervention effects would continue if implemented over longer periods (e.g., 60 min). 2) Across existing studies, dense reinforcement schedules are used and little is known about whether intervention effects would continue as reinforcement schedules are thinned to levels practical in natural settings. The investigators propose a project to address these gaps in the literature. Our proposed research plan builds off prior research investigating differential effects of matched (stimuli that produce effect similar to the presumed reinforcing effect of SIB) and unmatched (produce an effect dissimilar to that presumed to result from SIB) stimuli used as reinforcers in NCR and other DR-based interventions. The literature on intervention for automatically maintained SIB demonstrates that both matched and unmatched stimuli may reduce SIB in NCR and DR-based interventions. The investigators propose to evaluate relative effects of matched and unmatched stimuli (a) over time and (b) during schedule thinning. Because of the nature and importance of the topic, questions related to participant recruitment, extended session times planned for treatment evaluations, and measurement of procedural fidelity need to be addressed in a preliminary investigation. The current proposal will thus have the following aims.
Specific Aim 1: Demonstrate ability to meet enrollment requirements. The larger project (R01) proposed an enrollment of 50 participants over 5 years, with 40 participants anticipated to complete the studies. Enrollment target for this R56 will be seven to 10 participants evenly split across the two proposed studies. The investigators will randomize the first participant and then alternate assignment for subsequent participants. The investigators anticipate five to seven participants completing. Based on published data regarding reinforcement-based interventions for SIB maintained by automatic reinforcement, the investigators anticipate two-thirds of the participants will receive NCR and one-third will receive DRO. To assess feasibility of the defined recruitment targets, the investigators will collect data on the following: number of responses to recruitment efforts including, when possible, the proportion of possible participants who responded to recruitment efforts; proportion of potential participants who did not continue in the consent process following screen and the reason (e.g., declined further participation, screened out due to inclusion criteria); and proportion of participants and potential participants who exited the study at any point following initial screen as well as the reason (e.g., decided to withdraw).
Specific Aim 2: Evaluate acceptability and feasibility of participation relative to observation length and study duration. The larger study includes observation periods with intervention implemented for up to 180 min (3 hours) and an anticipated study duration of 24 weeks. To determine parent/caregiver acceptability of these longer session appointments, social validity will be measured over the course of the project using modified versions of the Parent Evaluation Inventory (PEI) and the Therapist Evaluation Inventory (TEI). Each measure includes 19 items and assesses the extent to which caregivers view interventions positively. The investigators will modify the instruments so that (a) they are appropriate for caregivers who are not parents (for May Institute participants whose caregivers will be teachers and direct care staff), and (b) assess the acceptability of procedural features (e.g., pre-intervention assessments, session duration) in addition to acceptability of the intervention. The PEI and TEI have been widely used in behavioral intervention studies. Investigators will administer the measures after completion of (1) pre-intervention assessment (preference assessment, functional analysis, COAB), (2) efficacy evaluation, and (3) intervention tests. As a further assessment of social validity, attendance and dropouts will be monitored and the investigators will continuously monitor participant assent to determine whether participants are more likely to withdrawal assent as observation periods increase. Data related to study duration for participants completing the study protocols will be used to more accurately propose individual participation timelines for the subsequent R01 application.
Specific Aim 3: Track participant progression. Participant progress through the study protocols will be tracked to determine if the individual timeline proposed is adequate, or requires adjustment. In particular, the investigators will evaluate whether the stated phase change criteria (currently based on IES SCD criteria) need to be adjusted to allow for either more efficient progress through the study phases or more convincing demonstration of experimental control.
Specific Aim 4: Demonstrate acceptable procedural fidelity with intervention implementation and Interobserver agreement (IOA).
Fidelity. The study will be conducted across two demonstration sites (May Institute and the University of Georgia). Thus, uniformity of implementation could vary. During the R56 period, the proposed training program will be implemented, and data will be collected on procedural fidelity and compared across sites.
Specifically, the investigators will directly measure procedural fidelity across all conditions to ensure the integrity of the procedures. Conforming with generally accepted practices in SCD, the investigators will use direct observation instruments reflective of the individual study protocols and evaluate for errors of omission and commission across at least 30% of all sessions, evenly distributed across study conditions and phases, for all participants and all implementers. These instruments typically consist of task analyses that specify what implementers should do (e.g., provide response-independent access to the reinforcer every 30 s), and what they should avoid (e.g., no vocal response from the therapist if SIB occurs). Investigators will then compute a measure of fidelity related (e.g., conditional probabilities of correct procedures and incorrect therapist behavior) to these two forms of errors relative to the planned steps and components for those conditions. Fidelity data will largely be collected in vivo, though recordings can be accessed if necessary (sometimes therapists and clients move out of frame of the camera so the investigators do not want to rely on video for fidelity data collection). To assist with procedural uniformity, May Institute will train implementers across sites and meet weekly with observers to review fidelity of implementation data and provide additional training. Adjustments to training procedures will be made or training boosters will be conducted if procedural fidelity drops below 90% for three consecutive implementations of any given procedure.
IOA: Mulitple data collectors will be responsible for in vivo data collection over the course of the study. To ensure that observation records reliably reflect what occurred during sessions, IOA will be tracked across all phases and conditions. Specifically, a second, naive, observer will collect data for IOA across all conditions using the same instrument as the primary data collector. Aligning with the generally accepted standards in SCD, these data will be gathered across at least 30% of sessions in each condition for each participant. The investigators will compare data between the observers to compute a measure of IOA. Data collectors will undergo a review of definitions and practice if IOA scores fall below 90% for three consecutive observations.
Specific Aim 5: Post hoc evaluation of subtype/intervention match. Following the conclusion of the study for each participant, the subtype of their SIB, the prescribed intervention, and the intervention outcome will be denoted. This process will allow for additional data sets related to subtype prevalence and subtype by intervention outcome to be collected. Individuals who exhibit SIB that fits Subtype 3 (i.e., SIB with self-restraint) will be reviewed on a case-by-case basis. If their self-restraint eliminates the occurrence of SIB, they will not be included in the study as SIB will not occur during the assessment phase.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study 1: Longevity
Study 1: Longevity will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as implementation durations are increased. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Implementation will gradually increase up to a maximum of three hours.
AUTOSIB across time
Intervention will be in place across increasing time frames.
Study 2: Schedule Thinning
Study 2: Schedule Thinning will evaluate the impact of matched and unmatched competing stimuli on reinforcement-based interventions as access to reinforcers decreases. Three conditions will be compared, using within-subjects single case designs: (a) baseline (no intervention), (b) intervention with competing stimuli matched to the hypothesized sensory consequences of SIB, and (c) intervention with competing stimuli unmatched to the hypothesized sensory consequences of SIB. Participants' specific intervention will be either noncontingent reinforcement (NCR) or differential reinforcement of other behavior (DRO), based on the outcomes of the pre-intervention assessments. During NCR, participants will receive access to competing stimuli on an ongoing and response-independent basis. During DRO, participants will receive access to competing stimuli contingent on the omission of SIB for a pre-determined length of time. Access to reinforcers will decrease across successful implementations.
AUTOSIB diminished reinforcement
Intervention will be in place with decreasing levels of reinforcement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AUTOSIB across time
Intervention will be in place across increasing time frames.
AUTOSIB diminished reinforcement
Intervention will be in place with decreasing levels of reinforcement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of intellectual and/or developmental disability
* Referred for assessment and treatment of self-injurious behavior
* Behavior maintained by automatic reinforcement function
Exclusion Criteria
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
May Institute
OTHER
University of Georgia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joel E. Ringdahl
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel E Ringdahl, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Georgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
May Institute
Randolph, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00006603
Identifier Type: -
Identifier Source: org_study_id